Chief Scientific Officer · Lyell Immunopharma, Inc. · Common Stock
Side
A
Value
—
Shares
4,000
Price
—
Executed
Feb 9, 2026
Disclosed
Feb 11, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 9 executedFeb 11, 2026 disclosed
LYEL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 27.1% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lee Gary K. filed this Form 4 reporting a grant or award of LYEL on Feb 9, 2026. It became public on Feb 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Lee Gary K.cik:0001907345
Issuer
Lyell Immunopharma, Inc.cik:0001806952
Revision history · 0
No field has changed since this record was first ingested.
